We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.6B
AUM Growth
+$570M
Cap. Flow
-$224M
Cap. Flow %
-1.27%
Top 10 Hldgs %
20.72%
Holding
1,372
New
93
Increased
502
Reduced
569
Closed
82

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$54.9M
2
ACN icon
Accenture
ACN
+$54.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$36.3M
4
IT icon
Gartner
IT
+$35.8M
5
HUM icon
Humana
HUM
+$32.6M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$61.7M
2
DHR icon
Danaher
DHR
+$38.4M
3
PGR icon
Progressive
PGR
+$36.4M
4
ADP icon
Automatic Data Processing
ADP
+$33.9M
5
PAYX icon
Paychex
PAYX
+$33.4M

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Healthcare 12.8%
3 Financials 9.66%
4 Consumer Discretionary 8.95%
5 Industrials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTWO icon
1076
Q2 Holdings
QTWO
$3.78B
$224K ﹤0.01%
9,097
+108
+1% +$3.21K
USFD icon
1077
US Foods
USFD
$22.5B
$223K ﹤0.01%
+6,029
New +$223K
LFUS icon
1078
Littelfuse
LFUS
$10.4B
$220K ﹤0.01%
820
-377
-31% -$96.9K
FCFS icon
1079
FirstCash
FCFS
$8.77B
$219K ﹤0.01%
2,297
-271
-11% -$24.5K
AOS icon
1080
A.O. Smith
AOS
$8.55B
$219K ﹤0.01%
+3,161
New +$205K
DH icon
1081
Definitive Healthcare
DH
$77M
$218K ﹤0.01%
21,102
+7,265
+53% +$85.5K
ING icon
1082
ING
ING
$92.9B
$216K ﹤0.01%
18,236
+2,855
+19% +$37.8K
NS
1083
DELISTED
NuStar Energy L.P.
NS
$216K ﹤0.01%
13,840
PBE icon
1084
Invesco Biotechnology & Genome ETF
PBE
$286M
$216K ﹤0.01%
3,439
-1,860
-35% -$120K
PRFT
1085
DELISTED
Perficient Inc
PRFT
$215K ﹤0.01%
+2,983
New +$218K
WHR icon
1086
Whirlpool
WHR
$2.49B
$215K ﹤0.01%
1,630
-105
-6% -$15K
FNV icon
1087
Franco-Nevada
FNV
$41.3B
$215K ﹤0.01%
+1,474
New +$206K
FMNB icon
1088
Farmers National Banc Corp
FMNB
$945M
$215K ﹤0.01%
17,000
-47
-0.3% -$650
GIB icon
1089
CGI
GIB
$15.6B
$215K ﹤0.01%
+2,230
New +$200K
FWRD icon
1090
Forward Air
FWRD
$461M
$214K ﹤0.01%
+1,990
New +$209K
J icon
1091
Jacobs Solutions
J
$16B
$214K ﹤0.01%
2,202
-7
-0.3% -$699
NATI
1092
DELISTED
National Instruments Corp
NATI
$212K ﹤0.01%
4,053
-1,848
-31% -$92.7K
CCEP icon
1093
Coca-Cola Europacific Partners
CCEP
$49.1B
$212K ﹤0.01%
+3,575
New +$200K
CYRX icon
1094
CryoPort
CYRX
$753M
$211K ﹤0.01%
8,804
-4,719
-35% -$103K
BRC icon
1095
Brady Corp
BRC
$4.46B
$211K ﹤0.01%
+3,924
New +$205K
VOX icon
1096
Vanguard Communication Services ETF
VOX
$5.68B
$209K ﹤0.01%
2,161
-4,406
-67% -$406K
BCE icon
1097
BCE
BCE
$20.8B
$208K ﹤0.01%
+4,635
New +$209K
PTH icon
1098
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$217M
$207K ﹤0.01%
5,541
BMO icon
1099
Bank of Montreal
BMO
$123B
$206K ﹤0.01%
2,314
+74
+3% +$7.02K
KBWB icon
1100
Invesco KBW Bank ETF
KBWB
$6.72B
$205K ﹤0.01%
4,890

Similar funds

Glenmede Trust's Q1 2023 Portfolio in Review

As of Q1 2023, Glenmede Trust held 1,372 positions worth $17.6B, up 3.3% from $17B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Glenmede Trust's Q1 2023 filing shows 93 new, 502 increased, 569 reduced and 82 closed positions. Its largest new stake was Zoom: 177,014 shares worth $13.1M. The largest sale was Advanced Micro Devices, an estimated $61.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q1 2023 buy was Zoom: 177,014 shares worth $13.1M.
  • Glenmede Trust added most to Procter & Gamble in Q1 2023, an estimated $54.9M increase.
  • Glenmede Trust's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $61.7M.
  • Glenmede Trust fully exited Matador Resources in Q1 2023, selling an estimated $17.9M.
  • Glenmede Trust's ten largest holdings make up 21% of its $17.6B portfolio in Q1 2023.
  • Glenmede Trust opened 93 new positions and closed 82 in Q1 2023.
  • Glenmede Trust's portfolio value rose 3.3% quarter-over-quarter to $17.6B.

Based on Glenmede Trust's 13F filing for Q1 2023, filed 15 May 2023.